Globally impact of Malaria Vaccines and brief history about it

Amol

posted on 3 years ago — updated on 1 second ago

563
views

Malaria Vaccines Market

According to World Health Organization statistics, about half of the world's population is at risk of malaria (WHO). As a result, numerous healthcare organisations have been more interested in solving this serious problem. The Melinda Gates Foundation and PATH, two global non-profit organisations, are trying to develop malaria prevention techniques and save the lives of many people in malaria-affected areas. Because Africa accounts for 90% of malaria occurrences, the launch of GlaxoSmithKline plc's first malaria vaccine is aimed primarily at this continent. Mosquirix was approved by the European Union in 2015 and is currently being tested in Africa as part of a pilot project.

https://bloggerthrive.blogspot.com/2022/02/globally-impact-of-malaria-vaccines-and.html

Click here for Malaria Vaccines Market Report:

https://www.coherentmarketinsights.com/market-insight/malaria-vaccines-market-37

Click here for Malaria Vaccines Market Press Release:

https://www.coherentmarketinsights.com/press-release/malaria-vaccines-market-to-surge-past-us-5918-million-by-2024-146

Amol

Working in Coherent Market Insights. Coherent Market Insights is a global market intelligence and consulting organization, focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan.